Company: Ichor Therapeutics, Inc.
Job title: Chief Executive Officer
Dr. Moody is a process-oriented drug developer who has specialized in the study of aging for over a decade. Since 2013, Dr. Moody has successfully built Ichor Therapeutics from a living room start-up into a premier, vertically integrated research organization focused on drug discovery for pathways of aging. R&D initiatives that constitute Ichor’s portfolio span enzyme therapy, senolytics, small molecule drug discovery, antibody mimetics, contract research and a strategic investment fund. Dr. Moody holds a PhD in biochemistry and molecular biology from the University of Miami Miller School of Medicine and an MBA in risk management from Concordia University Wisconsin.
Enzyme Augmentation Therapy for Age-Related Macular Degeneration 12:00 pm
day: Day Two